The 2016 Annual Report released by China Resources Phoenix Medical Holdings Co., Ltd. ("China Resources Phoenix" or "Group") recently showed that the Group actively purchased back the company's shares from the secondary market for further implementation of the share incentive plan. On April 10 and 11, 2017, the Group repurchased a total of 11 million shares of the company at an average price of HK$10.42 per share, involving a total consideration of approximately HK$115 million. The repurchase of shares fully demonstrates the Group's confidence in the company's share price and future development. After the completion of the share repurchase, the unsold shares held by the share incentive plan trustee increased to approximately 18.11 million shares, which will lay a solid foundation for the Group to vigorously promote the share incentive plan and the company's long-term development. Since July 2014, China Resources Phoenix has repeatedly purchased shares from the secondary market to implement the incentive plan, with remarkable results. At the end of 2014, the Group spent approximately HK$222 million to repurchase approximately 16.04 million shares from the secondary market; in early 2015, the Group repurchased approximately 2.14 million shares from the market. At this point, China Resources Phoenix has used the company's own funds of nearly 400 million Hong Kong dollars to purchase more than 30 million shares of the company in the secondary market. According to the share incentive plan, the repurchased shares will be mainly awarded to members of the management team of the company, management team members of subordinate hospitals and subsidiaries, medical experts and professional technical backbone. Currently, more than 10 million shares of the company have been granted to more than 120 employees. . The management of China Resources Phoenix said: “Medical health service is one of the industries with the greatest growth potential. With the government's policy of promoting the development of the medical and health industry, the depth and breadth of medical reform are continuously deepened, and the policies and markets for social capital to run medical care. The environment is in the best period in history. In addition to the consumption upgrade and the aging population, the rigid demand for medical services has become more obvious, bringing new development opportunities for China Resources Phoenix. While expanding, we deeply understand hospital management. The importance of talents and professional medical personnel for providing quality medical services, effective and consistent share incentive plans will truly achieve the consistency of the company's overall interests and personal interests of employees, and will help to attract outstanding talents to support the Group's long-term development. At the appropriate time, the company will continue to implement the incentive plan through share buybacks to maximize the benefits of employees, companies and shareholders." 2016 is a milestone for the Group. Phoenix Medical Group Co., Ltd. and China Resources Medical reorganized and changed its name to China Resources Phoenix Medical Holdings Co., Ltd. Through restructuring, China Resources Phoenix has achieved breakthrough development in its business scale and network layout. Through strong alliances, China Resources Phoenix's central enterprise advantages and marketization mechanisms have been organically integrated, and the industry has obvious competitive advantages. At present, the Group's annual outpatient volume is over 10 million person-times, and the operating medical institutions' total turnover is RMB 5.926 billion, which has established the Group's leading position in China's comprehensive medical service industry. In 2016, the Group recorded a revenue of RMB 1.533 billion, representing a year-on-year increase of 11.7%. After deducting non-recurring gains and losses, the Group's net profit exceeded RMB 250 million, excluding recurring profit and loss items compared to FY2015. After that, net profit increased by 28.9%. We provide wide range of herb tea cut, like echinacea tea, nettle leaf tea, dandelion root tea, valerian root tea and red raspberry leaf tea. We can provide blend herbal tea according to formula of customer and we also provide formula according to needs of customers. As one stop shop store of natural ingredients, tea bags like pyramid tea bag and string tea bag can be processed too. Private label is acceptable. Herb Tea Cut,Echinacea Tea,Nettle Leaf Tea,Dandelion Root YT(Xi'an) Biochem Co., Ltd. , https://www.ytherblifes.com